Descriptive Statistic | Retention in Care at 12 months N = 1341 | OR 95% CI | p value | Viral Suppression at 12 months VL < 200 copies/ml N = 1154 | OR 95% CI | p value |
---|---|---|---|---|---|---|
Sex | Â | 1.13 | 0.244 | Â | 0.85 | 0.09 |
 Male | 671 (50.0%) |  |  | 605 (52.4%) |  |  |
 Female | 670 (50.0%) | 0.92–1.38 |  | 549 (47.6%) | 0.71–1.03 |  |
Ethnicity (n = 1621) |  |  | 0.065 |  |  | 0.583 |
 African | 827 (71.3%) | Ref |  | 706 (71.2%) | Ref |  |
 East Indian | 78 (6.7%) | 0.829 0.50–1.37 |  | 72 (7.3%) 213 (21.5%) | 0.910 0.55–1.50 |  |
 Mixed/other | 255 (22.0%) | 1.19 0.84–1.67 |  |  | 1.18 0.85–1.65 |  |
Sexual orientation | Â | 0.936 | 0.669 | Â | 0.804 | 0.124 |
 Heterosexual | 1178 (87.8%) | 0.69–1.27 |  | 1022 (88.6%) | 0.61–1.06 |  |
 MSM | 158 (12.2%) |  |  | 132 (11.4%) |  |  |
Employment status (n = 1386) |  | 1.38 1.08–1.77 | 0.011 |  | 1.51 1.19–1.91 | 0.001 |
 Employed | 716 (73.1%) |  |  | 603 (74.6%) |  |  |
 Unemployed | 264 (26.9%) |  |  | 205 (25.4%) |  |  |
Drug use (crack/cocaine/marijuana) |  | 0.81 0.65–1.02 | 0.071 |  | 0.751 0.61–0.93 | 0.007 |
 Drug use | 346 (75.2%) |  |  | 286 (24.8%) |  |  |
 Non-drug use | 995 (78.5%) |  |  | 868 (75.2%) |  |  |
Baseline CD4 (n = 1859) |  | 1.27 1.02–1.58 | 0.033 |  | 1.33 1.09–1.63 | 0.005 |
 CD4 ≤ 200 | 154 (29.6%) |  |  | 412 (35.7%) |  |  |
 CD4 > 200 | 466 (70.4%) |  |  | 741 (64.3%) |  |  |
Years on ART |  |  |  < 0.001 |  |  |  < 0.001 |
 Never initiated ART | 13 (1.0%) |  |  | 7 (0.6%) |  |  |
 ≤ 3 years | 740 (55.2%) |  |  | 643 (55.7%) |  |  |
 4–6 years | 296 (22.1%) |  |  | 276 (23.9%) |  |  |
 7–9 years | 243 (18.1%) |  |  | 198 (17.2%) |  |  |
 ≥ 10 years | 49 (3.7%) |  |  | 30 (2.6%) |  |  |
Retention in care after 12 months |  |  |  |  | 3.18 2.58–3.19 |  < 0.001 |
 Retained |  |  |  | 933 (80.8%) |  |  |
 Not retained |  |  |  | 221 (19.2%) |  |  |